Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Favorites
Search by Keyword
Search by Category
Search by Format
Search by Type
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By
  • Contains 3 Component(s), Includes Credits

    This article will cover the significant areas, including: beyond-use dating for categories 1, 2, and 3 CSPs, requirements for clean room personnel qualification and evaluation, the need for a designated person(s) to ensure the sterile environment maintains quality, environmental monitoring changes and the need for increased testing and cleaning.

    On November 1, 2022 USP released the revised version of General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, which becomes enforceable November 1, 2023. Although revisions were proposed (and subsequently appealed) in previous years, this version will represent a significant change from the 2008 standards which are currently enforceable. Home infusion pharmacists, pharmacy technicians, nurses, and dietitians will need to comprehend how the updated standards apply to their sterile compounding operations. This article will cover the significant areas, including: beyond-use dating for categories 1, 2, and 3 CSPs, requirements for clean room personnel qualification and evaluation, the need for a designated person(s) to ensure the sterile environment maintains quality, environmental monitoring changes and the need for increased testing and cleaning.

    Learning Objectives:

    1. Review the latest updates to USP General Chapter <797> compared to the 2008 version which remains enforceable until November 1, 2023. 
    2. Understand the difference between Category 1, 2, and 3 compounded sterile preparations (CSPs) and list the specific requirements for each.
    3. Describe the requirements for personnel qualification and evaluation.
    4. Explain the increased frequencies for environmental monitoring and cleaning.

    NHIA General CE Information

    Abby Roth, BS, CMQ/OE

    Founder

    Pure Microbiology

    Abby Roth, founder of Pure Microbiology, has over 18 years of experience in supporting the testing and consulting needs of the pharmaceutical, medical device, and compounding industries. Her background in pharmaceutical microbiology includes extensive knowledge of environmental monitoring. Abby served as a USP Compounding EC member during the 2015-2020 cycle. She is an involved member of the Controlled Environment Testing Association (CETA), serving on the Board of Directors, speaking at its annual meetings, and chairing committees for the revision of four CETA Application Guides. Abby has been invited to speak for state boards of pharmacy and for national organizations.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

     Abby Roth has no relevant financial relationships with ineligible companies to disclose.

  • Contains 2 Component(s)

    Join us for an inspiring webinar showcasing the exceptional work of this year’s finalists for the NHIA Outstanding Abstract Achievement Award.

    Join us for an inspiring webinar showcasing the exceptional work of this year’s finalists for the NHIA Outstanding Abstract Achievement Award. These innovative researchers and practitioners have made significant contributions to the field, addressing critical challenges and advancing best practices. During this session, each finalist will present their abstract, highlighting key findings, methodologies, and the real-world impact of their work. The award winner will be announced live at the 2025 NHIA Annual Conference in Washington D.C.

    Katie Laskin, PharmD, BCSCP, CNSC

    Clinical Pharmacist

    Yale New Haven Home Infusion

    Katie Laskin, PharmD, BCSCP, CNSC is a Clinical Pharmacist with Yale New Haven Health's Home Infusion program. She received her PharmD from the University of Connecticut in 2005 and has been working in home infusion in various roles since 2006. She is a Board Certified Sterile Compiunding Pharmacist and a Certified Nutrition Support Clinician.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Katie Laskin has no relevant financial relationships with ineligible companies to disclose.

    Natalie Garcia, PharmD

    Pharmacy Resident

    Option Care Health

    Currently employed as a PGY-1 Pharmacy Resident at Option Care Health. Graduated from University of Connecticut with a Bachelors in Molecular and Cell Biology. Graduated from the University of Saint Joseph School of Pharmacy with a Doctor of Pharmacy. Experienced information technology support manager with demonstrated history of working in the higher education industry and previous pharmacy retail experience as a CVS pharmacy intern. Skilled in Healthcare, Data Analysis, Technical Support, and Project Management and specialized in the home infusion setting.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Natalie Garcia has no relevant financial relationships with ineligible companies to disclose.

    Leslie Myers, PharmD, IgCP

    Integrated Clinical Services Manager

    CSI Pharmacy

    Dr. Leslie Myers, PharmD, IgCP has a wealth of experience in the field of immunoglobulin therapies with a strong background as a clinical pharmacist within the realm of specialty home infusion. Her dedication to enhance patients’ lives requiring clinical intervention through specialty medications aligns perfectly with the culture at CSI. She earned her Doctor of Pharmacy degree from Campbell University in 2008, graduating summa cum laude.  Leslie was the founding president of the Women’s Integration Network within AMCP and also enjoys working with Immunoglobulin National Society (IgNS) through multiple committee roles and development of national Ig Therapy Standards of Practice. 

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Leslie Myers has no relevant financial relationships with ineligible companies to disclose.

    Amy Braglia-Tarpey, MS, RD, CNSC

    Director Nutrition Product Line

    Amerita

    Amy Braglia-Tarpey is a registered dietitian and earned the designations of board-certified specialist in renal nutrition and certified nutrition support clinician. She received her BA from the University of Arizona and MS degree in Nutritional Science from California State University, Long Beach. Amy began her career as a renal & research dietitian, and then transitioned to specialty infusion, with progressive sales, clinical, and leadership roles. Amy's passions include access to care and quality of life. She enjoys sharing her expertise through publications, speaking engagements, clinician education, and collaborative projects. Amy is Director of Nutrition Product Line for Amerita Specialty Infusion.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Amy Braglia-Tarpey has no relevant financial relationships with ineligible companies to disclose.

    Kascha Brown, PharmD

    Pharmacy Resident

    Option Care Health

    Kascha Brown is a PGY1-Resident with Option Care Health. She has a diverse background that includes teaching high school science, health disparities research, breast cancer research, and youth mentoring. Kascha obtained her Bachelor of Science degree in Biology from Howard University, Master of Science degree in Molecular Biology and Biochemistry from University of Illinois at Chicago. Kascha received Doctor of Pharmacy degree from Roosevelt University. Kascha's clinical interests include pharmacogenomics and infectious disease.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Kascha Brown has no relevant financial relationships with ineligible companies to disclose.

  • Contains 4 Component(s), Includes Credits

    This article provides information on standardized assessment tools, common home infusion-related infections, and interdisciplinary involvement in patient monitoring and communication among providers.

    Home infusion clinicians need to effectively address sepsis in patients through early recognition, prompt intervention, and a collaborative approach. This article provides information on standardized assessment tools, common home infusion-related infections, and interdisciplinary involvement in patient monitoring and communication among providers.  

     Learning Objectives:

    1. Describe sepsis and its clinical manifestations in the home infusion setting.
    2. Identify key risk factors of sepsis in home infusion patients to facilitate early recognition and intervention.
    3. Discuss monitoring strategies for home infusion therapy patients to prevent and manage infections.
    4. Determine the most common home infusion-related infections and their prevention strategies. 

    Anthony Casapao, PharmD, MPH, BCIDP, FIDSA

    Clinical Associate Professor

    University of Florida College of Pharmacy

    He earned his Doctor of Pharmacy degree from Wingate University. He then completed postgraduate pharmacy practice and infectious diseases residency training at St. Vincent’s Medical Center and the University of Pittsburgh Medical Center, respectively. He continued his love of infectious diseases by completing a fellowship in health economics and outcomes research at Wayne State University. He further developed his research skills by completing a master's degree in public health with a concentration in Epidemiology and Biostatistics at Harvard University.

    His research focuses on pharmacoepidemiology, evaluating post-marketing data, and applying more extensive data to understand public health problems and explore possible solutions. He also focuses on the off-label use of antimicrobials with comparative effectiveness methodologies, expanding on previous subject knowledge, applying more robust data, and providing confirmatory conclusions for controversial data. His substantial research focuses on antimicrobial resistance and the clinical implications of anti-infective therapies from a One Health perspective.

    Dr. Casapao has published extensively in peer-reviewed journals and is a Fellow of the Infectious Diseases Society of America. At the University of Florida, he teaches, mentors, and guides students through their professional development, particularly in infectious diseases.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Anthony Casapao has no relevant financial relationships with ineligible companies to disclose.

    Tiffany Hart, BS

    PharmD Candidate

    University of Florida College of Pharmacy

    Tiffany Hart is a PharmD candidate at the University of Florida College of Pharmacy, expected to graduate in May of 2025. She previously earned a Bachelor of Science in Psychology with a focus on counseling psychology from the University of Florida. Tiffany has a particular interest in pediatrics, neonatology, infectious disease, and psychiatric pharmacy, and is passionate about advancing care in these specialties through clinical practice and research. Tiffany is currently pursuing a residency program with the goal of becoming a clinical pediatric pharmacist, where she hopes to integrate her interests in pediatric care and infectious disease to improve patient outcomes.

    In addition to her academic achievements, Tiffany is an active student leader at the University of Florida. She co-founded the Asian Student Pharmacist Coalition (ASPC) in 2022 and served as President for two terms, fostering community and advocating for diversity within the pharmacy program. Tiffany is also a dedicated Student Ambassador and Pharmacy Early Acceptance Program Mentor, roles through which she champions student advocacy and enhances representation of the profession. Although this is Tiffany's first publication, she is excited to continue contributing to medical writing and research throughout her career.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Tiffany Hart has no relevant financial relationships with ineligible companies to disclose.

    Olga Afanaseva, MS

    PharmD Candidate

    University of Florida College of Pharmacy

    I am a second-year PharmD student at the University of Florida College of Pharmacy. I was born in Russia and relocated to the United States with my family in 2018. I am passionate about clinical pharmacy and infectious diseases, with a strong interest in pharmacotherapy and patient care.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Olga Afanaseva has no relevant financial relationships with ineligible companies to disclose.

    Timber Abinsay, AA

    PharmD Candidate

    University of Florida College of Pharmacy

    Timber Abinsay is currently a second year pharmacy student at the University of Florida College of Pharmacy at the Jacksonville Campus and is expected to graduate in May 2027. She plans on doing a residency after graduation and her current areas of interest are Emergency Medicine, Critical Care, and Ambulatory Care. She hopes to make a difference in the lives of her patients and to advocate for her patients care which is her main motivation for being a pharmacist.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Timber Abinsay has no relevant financial relationships with ineligible companies to disclose.

  • Contains 3 Component(s), Includes Credits Recorded On: 09/20/2023

    This presentation will focus on evaluating stability studies of parenteral drugs as a vital step in determining an appropriate BUD for CSPs.

    When manufacturer product labeling provides limited or no guidance on usage timeframes, published stability studies can help justify extending the beyond-use date (BUD) of a compounded sterile preparation (CSP). This presentation, tailored for pharmacists, pharmacy technicians, nurses, and dietitians, will focus on evaluating stability studies of parenteral drugs as a vital step in determining an appropriate BUD for CSPs.

    Learning Objectives:

    1. Navigate the literature resources and review drug stability studies for validity.
    2. Assess the applicability of a drug stability study to assigning a beyond-use date to a compounded sterile preparation.
    3. Differentiate the changes made in USP <797>, analyze how these impact the beyond-use date. 

    NHIA General CE Information

    Michelle Simpson, PharmD, BCSCP, MWC

    Clinical Program Manager

    National Home Infusion Association

    Michelle C. Simpson, PharmD, BCSCP, MWC, is a Board Certified Sterile Compounding Pharmacist with an established career in home infusion. She is the Clinical Program Manager for the National Home Infusion Association (NHIA), where she is responsible for research studies, non-profit foundation initiatives, data benchmarking, and clinical education development. Michelle is Editor in Chief of Infusion Journal, a peer-reviewed scholarly publication that features independent original research on infusion therapies and is published by the National Home Infusion Foundation (NHIF). Michelle is Co-Editor of Extended Stability for Parenteral Drugs, 7th Edition, a publication of the American Society of Health-System Pharmacists (ASHP). 

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Michelle Simpson has no relevant financial relationships with ineligible companies to disclose.

    Christpher Roy, PharmD, BCSCP

    Pharmacist Training Specialist

    Option Care Health

    Chris Roy, PharmD, BCSCP, began his career with Option Care Health in 2018 as a PGY-1 resident. Since that point, he has held roles as a Clinical Pharmacist, Pharmacy Supervisor, and currently is the Pharmacist Training Specialist with Option Care Health. Chris believes that proper training and education are key to the future of the pharmacy profession and necessary to further the home infusion industry.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Christopher Roy has no relevant financial relationships with ineligible companies to disclose.

  • Contains 9 Component(s), Includes Credits Includes Multiple Live Events. The next is on 02/24/2026 at 12:00 PM (EST) Recorded On: 02/26/2026

    This three-part series prepares home infusion nurses to navigate accreditation audits with clarity, confidence, and composure. From daily best practices and audit expectations to mindset strategies for first-time visits, participants will gain the tools to turn readiness into routine and elevate professional presence under pressure.

    Nurse Bytes: Nurse Tips for Audit-Readiness

    This session offers the home infusion nurse practical steps in every day practice which prepares the nurse for an accreditation audit. 

    1. Describe how to manage the patient's home for survey readiness.
    2. Develop a process for managing initial and ongoing competencies. 
    3. Identify areas of gaps in current practice.

    Nurse Necessities: "Audit Alert: What Every Home Infusion Nurse Should Know"

    This session offers home infusion nurses a deeper understanding into what is being observed and audited during an accreditation patient visit. Nurses will gain practical insight into the audit process, including standards that apply to the home infusion nurse. 

    1. Describe the purpose of patient visits as part of the accreditation 
    2. Recognize the clinical scope that accreditation auditors assess during patient visits.
    3. Explain key components for nursing documentation that are commonly observed and audited during accreditation visits.

    Nurse Bytes: Strategies for Overcoming Stage Fright: In Front of an Auditor for the First Time

    This follow-up session helps home infusion nurses build confidence and composure when facing an auditor for the first time. Through practical strategies, mindset shifts, and real-world examples, participants will learn how to turn audit anxiety into professional readiness and poise.

    1. Describe key strategies to prepare for a patient visit.
    2. Discuss common pitfalls associated with audit visits.
    3. Develop training for field nurses to prepare for patient visits.

    ***Full front matter document will be attached for all 3 sessions

    Leslie Myers, PharmD, IgCP

    Integrated Clinical Services Manager

    CSI Pharmacy

    Dr. Leslie Myers, PharmD, IgCP has a wealth of experience in the field of immunoglobulin therapies with a strong background as a clinical pharmacist within the realm of specialty home infusion. Her dedication to enhance patients’ lives requiring clinical intervention through specialty medications aligns perfectly with the culture at CSI. She earned her Doctor of Pharmacy degree from Campbell University in 2008, graduating summa cum laude.  Leslie was the founding president of the Women’s Integration Network within AMCP and also enjoys working with Immunoglobulin National Society (IgNS) through multiple committee roles and development of national Ig Therapy Standards of Practice. 

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Leslie Myers has no relevant financial relationships with ineligible companies to disclose.

  • Contains 3 Component(s), Includes Credits Recorded On: 11/20/2024

    This program will provide best practices on how to manage patient's individualized dressing needs and ensure they have a positive experience with quality outcomes.

    Deciding what dressing to use for different patients can be an interesting challenge for nurses taking care of home infusion patients. Patients have different needs and, in some situations, "one dressing doesn't fit all". This program will provide best practices on how to manage patient's individualized dressing needs and ensure they have a positive experience with quality outcomes. 

    Learning Objectives:

    1. Differentiate various challenges of catheter dressing changes.
    2. Describe interventions to identify, prevent and manage skin complexities during a dressing change. 
    3. Identify barriers to implementing these interventions and how to mitigate them. 
    4. Discuss how interprofessional collaboration is essential for optimal patient outcomes. 

    NHIA General CE Information

    Shannon Ryan

    Nurse Education Specialist

    Naven Health

    Shannon is a Nurse Education Specialist with Naven Health, which is a nationwide network of infusion nurses providing specialized therapies, drug administration, clinical trial services and special programs support. Shannon is a Registered Nurse with over 10 years of focused infusion therapy experience. In her role at Naven Health, Shannon focuses on nurse training, education, support and quality improvement.

    NHIA requires planners, faculty, and others who are able to control the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.

    Shannon Ryan has no relevant financial relationships with ineligible companies to disclose.

  • Contains 3 Component(s), Includes Credits Recorded On: 10/15/2025

    This presentation offers a comprehensive guide to best practices for responding to reimbursement audits. Attendees will learn how to prepare in advance, respond effectively to audit requests, and implement post-audit improvements.

    Reimbursement audits can be daunting, but with the right preparation and strategies, healthcare providers can navigate them efficiently while maintaining compliance and minimizing financial risks. This presentation offers a comprehensive guide to best practices for responding to reimbursement audits. Attendees will learn how to prepare in advance, respond effectively to audit requests, and implement post-audit improvements. Emphasis will be placed on building a culture of compliance and utilizing audits as opportunities for growth and refinement in billing and documentation practices.

    Learning Objectives:

    1. Basic understanding of the various Medicare audit contractors and the role they each play.
    2. Understand the potential impact audits can have on a provider or supplier.
    3. Best practice recommendation to mitigate the impact of Medicare audits.

    NHIA General CE Information

    Noel Neil, JM, CDME

    Chief Compliance Officer

    Acu-Serve LLC

    An expert in the areas of billing, auditing, appeals and regulatory compliance, Noel serves as Chief Compliance at ACU-Serve LLC, where he is responsible for maintaining and monitoring the company’s corporate compliance program. He also offers audit defense and policy-specific education and guidance to ACU-Serve’s existing clients, representing multiple suppliers in all types of Medicare audits and appeals, from the initial request to the Administrative Law Judge (ALJ) and in some cases, the Department of Appeals Board (DAB). Noel has over 18 years in the DMEPOS industry working in Intake, Billing and Compliance Departments throughout his tenure. Noel also helps DMEPOS providers navigate the complex terrain of reimbursement and profitability of potential products, with an eye toward helping them grow their business compliantly. He also serves as subject matter expert in litigation support on DMEPOS billing and compliance. Noel is an active member and contributor of all four Medicare Councils, and he serves as the Vice Chair to the Jurisdiction C Council and the Complex Rehab A Team Leader for the Jurisdiction B and D Councils. He also serves on the Medicare Provider Outreach and Education Advisory Groups for Jurisdictions A, C and D, and MYCGS Advisory Group. Noel actively participates in industry Councils and Advisory Committee such the AAHomecare’s Regulatory Council, Diabetes Council, Payer Relations Council and the NHIA Medicare Contractor Advisory Committee. Noel enjoys speaking and interacting with suppliers and stakeholders at trade shows, state associations and other industry exclusive summits and events. Noel received a Juris Masters (JM) Law Degree, from Florida State University College of Law, with a concentration in Health Care Regulation. Noel is also a Board of Certification/Accreditation (BOC), Certified Durable Medical Equipment Specialist (CDME) and a subject matter expert (SME) for the 2021 - 2022 revision of the CDME exam.

    Noel was voted BOC’s 2023 Certificant of Year for his outstanding contributions to the profession, including commitments to service, research and outreach. Noel Neil Named BOC Certificant of the Year - Board of Certification/Accreditation

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Noel Neil has no relevant financial relationships with ineligible companies to disclose.

  • Contains 4 Component(s), Includes Credits

    This article provides practical guidance for health care professionals delivering home infusion therapy to children and teens with ASD. It highlights the unique sensory, communication, and behavioral challenges these patients may face, offering evidence-based strategies to create supportive, individualized care experiences.

    This article provides practical guidance for health care professionals delivering home infusion therapy to children and teens with ASD. It highlights the unique sensory, communication, and behavioral challenges these patients may face, offering evidence-based strategies to create supportive, individualized care experiences. Key approaches include preparing families through collaborative planning, adjusting the home environment to be sensory-friendly, using visual schedules and communication supports, applying behavioral reinforcement techniques, and managing procedures with empathy and flexibility. Through case studies and actionable recommendations, the article emphasizes the importance of patience, collaboration, and tailoring care to foster trust, comfort, and improved outcomes for patients and their families. This article is targeted to pharmacists, pharmacy technicians, nurses, and dietitians.

    Learning Objectives:

    1. Understand the possible challenges children with ASD experience that may affect the delivery of home infusion care.
    2. List modified approaches that home infusion providers can employ to accommodate those challenges.
    3. Construct a care plan for a home visit that incorporates techniques of gradual introduction, sensory-friendly environment, visual and sensory schedules, and behavioral support and reinforcement.

    Dr Kenneth Shamlian

    Associate Professor of Pediatrics Director, Pediatric IDD Behavioral Health Services

    University of Rochester Medical Center

    Dr. Kenneth Shamlian is a licensed pediatric psychologist and Associate Professor of Pediatrics at the University of Rochester School of Medicine. He directs the Pediatric Intellectual and Developmental Disability (IDD) Behavioral Health Services at Golisano Children’s Hospital. Specializing in Developmental and Behavioral Pediatrics and Pediatric Sleep Medicine, he is a diplomate in behavioral sleep medicine, addressing complex sleep challenges in the IDD population. Dr. Shamlian also uses evidence-based approaches to treat elimination disorders, challenging behavior, developmental skill deficits, and independent health skills development. A passionate advocate for equity and inclusion, he works to expand healthcare capacity and improve care for individuals with developmental disabilities.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Dr Kenneth Shamlian has no relevant financial relationships with ineligible companies to disclose.

     

    Angeles Nunez, MS, CCLS, CPMT

    Certified Child Life Specialist

    Holtz Children's Hospital

    Angeles Nunez, MS, CCLS, CPMT has been a Certified Child Life Specialist for 9 years, providing psychosocial support and education for children and families dealing with the challenges of illness, disability and/or hospitalization. She received her Bachelor's degree in Early Care and Education with a Psychology minor from Florida Atlantic University and her MS in Human Development with a concentration in Developmental Differences from the University of Rochester. She is trained as an autism navigator, as well as trained in pediatric massage, kids yoga, disaster relief for children and families, and sibling support programming. She also has experience working with children and families in the fields of special education/applied behavior analysis programming, pediatric rehabilitation and pediatric intensive care.

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Angeles Nunez has no relevant financial relationships with ineligible companies to disclose.

  • Contains 9 Component(s), Includes Credits Includes Multiple Live Events. The next is on 02/17/2026 at 12:00 PM (EST) Recorded On: 02/19/2026

    This three-part series empowers healthcare professionals and operational leaders to move beyond audit checklists and build a culture of continuous readiness. From identifying common deficiencies to aligning improvement strategies with organizational goals, participants will gain practical tools to embed accreditation standards into daily operations and drive lasting impact.

    Operation Ignite: Common Accreditation Deficiencies

    This session will introduce professionals to an overview of the most common deficiencies found during an accreditation audit.

    1. Describe the most common areas of deficiencies cited.
    2. Identify competency deficiencies in specialty pharmacy and nursing.
    3. Formulate a plan to review and address common deficiencies in your organization

    Operation Elevation: Process Changes to Improve Patient Outcomes

    This session explores how leaders can transform accreditation deficiencies into actionable opportunities through a robust quality improvement framework. Participants will learn strategies to align compliance gaps with performance goals, driving sustainable improvements in patient care and organizational outcomes.

    1. Analyze the current state of improvement activities driven by deficiencies.
    2. Describe how to transform accreditation deficiencies into improvement opportunities.
    3. Apply learned strategies to drive sustainable improvements in patient care and organizational outcomes.

    Operation Ignite: Practical Steps to Ensure Accreditation Standard Sustainability

    This follow-up session offers operational leaders practical strategies to embed accreditation standards into daily operations, fostering long-term compliance and continuous improvement. Participants will explore tools and routines that transform readiness from a one-time event into a sustained culture of excellence.

    1. Apply practical strategies for accreditation integration.
    2. Develop tools and routines for continuous readiness.
    3. Foster long-term compliance and excellence.

    ***Full front matter document will be attached for all 3 sessions

    Leslie Myers, PharmD, IgCP

    Integrated Clinical Services Manager

    CSI Pharmacy

    Dr. Leslie Myers, PharmD, IgCP has a wealth of experience in the field of immunoglobulin therapies with a strong background as a clinical pharmacist within the realm of specialty home infusion. Her dedication to enhance patients’ lives requiring clinical intervention through specialty medications aligns perfectly with the culture at CSI. She earned her Doctor of Pharmacy degree from Campbell University in 2008, graduating summa cum laude.  Leslie was the founding president of the Women’s Integration Network within AMCP and also enjoys working with Immunoglobulin National Society (IgNS) through multiple committee roles and development of national Ig Therapy Standards of Practice. 

    NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy. 

    Leslie Myers has no relevant financial relationships with ineligible companies to disclose.

  • Contains 10 Component(s), Includes Credits Includes Multiple Live Events. The next is on 12/08/2026 at 12:00 PM (EST) Recorded On: 12/10/2026

    This three-part series equips home infusion professionals with the tools to navigate billing scenarios that fall outside standard workflows. From assessing financial risk at intake to managing one-off cases and building sustainable internal processes, participants will gain practical strategies to protect revenue integrity and improve consistency in complex billing environments.

    Operation Ignite: Identifying Non-Routine Scenarios in Home Infusion Billing

    This introductory session will help attendees recognize the types of situations that fall outside standard billing workflows. Participants will explore common triggers for non-routine cases—such as uncontracted payers, unique therapy types, or new referral relationships—and learn how to assess potential financial and operational impacts early in the intake process. The session sets the stage for effective decision-making when standard billing procedures don’t apply.

    Operation Elevation: Managing Non-Routine Home Infusion Billing Scenarios

    Home infusion providers often encounter unique scenarios that fall outside standard billing processes—such as new referral sources or patients whose insurance is not contracted with the provider. This session will focus on strategies for managing these one-off situations, including determining coverage options, establishing patient financial responsibility, and implementing best practices to minimize delays or denials. Attendees will gain practical guidance to make informed decisions and maintain revenue cycle integrity in complex, non-routine cases.

    Operation Ignite: Developing Internal Processes for Complex Billing Management

    Building on the main session, this discussion will focus on creating sustainable internal workflows for handling non-routine cases. Attendees will learn how to document decision pathways, communicate effectively across departments, and track outcomes to identify recurring patterns. The session will highlight how a proactive framework and continuous review process can strengthen compliance, reduce revenue risk, and improve consistency in handling unique billing situations.

    ***Full front matter document will be attached for all 3 sessions